Suchergebnisse - (Person:"De Meyer, Sandra")

PubPharm (7)

1

HIV-1 resistance rarely observed in patients using darunavir once-daily regimens across clinical studies

enthalten in: HIV clinical trials | 2017

von Lathouwers, E. | Wong, E. | Luo, D. | +3

2

Deep sequencing analysis of HIV-1 reverse transcriptase at baseline and time of failure in patients receiving rilpivirine in the phase III studies ECHO and THRIVE

enthalten in: Journal of medical virology | 2016

von Van Eygen, V. | Thys, K. | Van Hove, C. | +5

3

Assessment of etravirine resistance in HIV-1-infected paediatric patients using population and deep sequencing : final results of the PIANO study

enthalten in: Antiviral therapy | 2016

von Tambuyzer, L. | Thys, K. | Hoogstoel, A. | +5

4

Trends in darunavir resistance-associated mutations and phenotypic resistance in commercially tested United States clinical samples between 2006 and 2012

enthalten in: AIDS research and human retroviruses | 2015

von Lathouwers, E. | Gupta, S. | Haddad, M. | +3

5

Virological analysis of once-daily and twice-daily darunavir/ritonavir in the ODIN trial of treatment-experienced patients

enthalten in: Antiviral therapy | 2013

von Lathouwers, E. | De La Rosa, G. | Van de Casteele, T. | +4

6

Virological characterization of patients failing darunavir/ritonavir or lopinavir/ritonavir treatment in the ARTEMIS study : 96-week analysis

enthalten in: Antiviral therapy | 2011

von Lathouwers, E. | De Meyer, S. | Dierynck, I. | +4

7

Short communication : activity of etravirine on different HIV type 1 subtypes: in vitro susceptibility in treatment-naive patients and week 48 pooled DUET study data

enthalten in: AIDS research and human retroviruses | 2010

von Vingerhoets, J. | Azijn, H. | Tambuyzer, L. | +7

1
[1]